http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011105659-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3cd3ea6c52ef8544c67c051a2ef489b3 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985 |
| filingDate | 2009-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_323ce54d19671197a821d412b6e35477 |
| publicationDate | 2011-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2011105659-A |
| titleOfInvention | Indolo [2,3-b] quinoxaline compound having erythropoietin production promoting action |
| abstract | The present invention provides a compound having a low molecular weight EPO (erythropoietin) production promoting action. An indolo [2,3-b] quinoxaline compound represented by the following formula: [Wherein, R 1 represents a hydrogen atom, a C 1-6 alkyl group, a carboxy-C 1-6 alkyl group, a C 2-7 alkoxycarbonyl-C 1-6 alkyl group, R 2 and R 3 represent a hydrogen atom. Or a halogen atom, R 4 is a hydrogen atom, a halogen atom, or a nitro group] [Selection figure] None |
| priorityDate | 2009-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 153.